First Time Loading...
B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 0.54 HKD Market Closed
Updated: Apr 25, 2024
Section:
 

Intrinsic Value

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. [ Read More ]

The intrinsic value of one Broncus Holding Corp stock under the Base Case scenario is 0.39 HKD. Compared to the current market price of 0.54 HKD, Broncus Holding Corp is Overvalued by 29%.

Key Points:
Intrinsic Value
Base Case
0.39 HKD
Overvaluation 29%
Intrinsic Value
Price
B
Base Case Scenario
What is intrinsic value?

Valuation Backtest
Broncus Holding Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Broncus Holding Corp stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Broncus Holding Corp

What unique competitive advantages
does Broncus Holding Corp hold over its rivals?

What risks and challenges
does Broncus Holding Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Broncus Holding Corp.

Provide an overview of the primary business activities
of Broncus Holding Corp.

What unique competitive advantages
does Broncus Holding Corp hold over its rivals?

What risks and challenges
does Broncus Holding Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Broncus Holding Corp.

Provide P/S
for Broncus Holding Corp.

Provide P/E
for Broncus Holding Corp.

Provide P/OCF
for Broncus Holding Corp.

Provide P/FCFE
for Broncus Holding Corp.

Provide P/B
for Broncus Holding Corp.

Provide EV/S
for Broncus Holding Corp.

Provide EV/GP
for Broncus Holding Corp.

Provide EV/EBITDA
for Broncus Holding Corp.

Provide EV/EBIT
for Broncus Holding Corp.

Provide EV/OCF
for Broncus Holding Corp.

Provide EV/FCFF
for Broncus Holding Corp.

Provide EV/IC
for Broncus Holding Corp.

Show me price targets
for Broncus Holding Corp made by professional analysts.

What are the Revenue projections
for Broncus Holding Corp?

How accurate were the past Revenue estimates
for Broncus Holding Corp?

What are the Net Income projections
for Broncus Holding Corp?

How accurate were the past Net Income estimates
for Broncus Holding Corp?

What are the EPS projections
for Broncus Holding Corp?

How accurate were the past EPS estimates
for Broncus Holding Corp?

What are the EBIT projections
for Broncus Holding Corp?

How accurate were the past EBIT estimates
for Broncus Holding Corp?

Compare the revenue forecasts
for Broncus Holding Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Broncus Holding Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Broncus Holding Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Broncus Holding Corp compared to its peers.

Compare the P/E ratios
of Broncus Holding Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Broncus Holding Corp with its peers.

Analyze the financial leverage
of Broncus Holding Corp compared to its main competitors.

Show all profitability ratios
for Broncus Holding Corp.

Provide ROE
for Broncus Holding Corp.

Provide ROA
for Broncus Holding Corp.

Provide ROIC
for Broncus Holding Corp.

Provide ROCE
for Broncus Holding Corp.

Provide Gross Margin
for Broncus Holding Corp.

Provide Operating Margin
for Broncus Holding Corp.

Provide Net Margin
for Broncus Holding Corp.

Provide FCF Margin
for Broncus Holding Corp.

Show all solvency ratios
for Broncus Holding Corp.

Provide D/E Ratio
for Broncus Holding Corp.

Provide D/A Ratio
for Broncus Holding Corp.

Provide Interest Coverage Ratio
for Broncus Holding Corp.

Provide Altman Z-Score Ratio
for Broncus Holding Corp.

Provide Quick Ratio
for Broncus Holding Corp.

Provide Current Ratio
for Broncus Holding Corp.

Provide Cash Ratio
for Broncus Holding Corp.

What is the historical Revenue growth
over the last 5 years for Broncus Holding Corp?

What is the historical Net Income growth
over the last 5 years for Broncus Holding Corp?

What is the current Free Cash Flow
of Broncus Holding Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Broncus Holding Corp.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Broncus Holding Corp

195.8m
Assets
10.4m
Liabilities
195.8m
Assets
10.4m
Liabilities
Current Assets 172.7m
Cash & Short-Term Investments 156.4m
Receivables 10m
Other Current Assets 6.3m
Non-Current Assets 23.2m
Long-Term Investments 8.9m
PP&E 4.6m
Intangibles 9m
Other Non-Current Assets 750k
Current Liabilities 9.2m
Accounts Payable 399k
Other Current Liabilities 8.8m
Non-Current Liabilities 1.3m
Long-Term Debt 1.2m
Other Non-Current Liabilities 53k
Efficiency

Earnings Waterfall
Broncus Holding Corp

Revenue
10.3m USD
Cost of Revenue
-3m USD
Gross Profit
7.2m USD
Operating Expenses
-35.4m USD
Operating Income
-28.1m USD
Other Expenses
49k USD
Net Income
-28.1m USD
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Broncus Holding Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Broncus Holding Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Negative ROE
Negative Operating Income
24/100
Profitability
Score

Broncus Holding Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Broncus Holding Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Broncus Holding Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Broncus Holding Corp

Wall Street analysts forecast Broncus Holding Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Broncus Holding Corp is 1.53 HKD with a low forecast of 1.52 HKD and a high forecast of 1.58 HKD.

Lowest Forecast
Wall Street Target
1.52 HKD
181% Upside
Average Forecast
Wall Street Target
1.53 HKD
183% Upside
Highest Forecast
Wall Street Target
1.58 HKD
192% Upside
Lowest
Price Target
1.52 HKD
181% Upside
Average
Price Target
1.53 HKD
183% Upside
Highest
Price Target
1.58 HKD
192% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Broncus Holding Corp

1M 1M
-7%
6M 6M
-45%
1Y 1Y
-70%
3Y 3Y
-96%
5Y 5Y
-96%
10Y 10Y
-96%
Annual Price Range
0.54
52w Low
0.495
52w High
1.83
Price Metrics
Average Annual Return -57.36%
Standard Deviation of Annual Returns 23.88%
Max Drawdown -97%
Shares Statistics
Market Capitalization 263.9m HKD
Shares Outstanding 527 198 060
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Broncus Holding Corp

Country

China

Industry

Health Care

Market Cap

263.9m HKD

Dividend Yield

0%

Description

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Contact

ZHEJIANG
Hangzhou
Room 801, 8/F, Building 8, No. 88 Jiangling Road, Xixing Street, Binjiang District
http://www.broncus.com/

IPO

2021-09-24

Employees

245

Officers

CEO & Executive Director
Mr. Hong Xu
VP, Operation Director & Scientist in resident
Thomas M. Keast
Sr. Accountant
Feng Yao
Director of Finance & Administration
Ms. Elaine Lu
Company Secretary
Ms. Yin Kwan Ho

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one Broncus Holding Corp stock?

The intrinsic value of one Broncus Holding Corp stock under the Base Case scenario is 0.39 HKD.

Is Broncus Holding Corp stock undervalued or overvalued?

Compared to the current market price of 0.54 HKD, Broncus Holding Corp is Overvalued by 29%.

ALPHA SPREAD
Join more than 131,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.